Idaho - Minimum Dataset and Data Dictionary - 2018 · Idaho - Minimum Dataset and Data Dictionary -...

Idaho - Minimum Dataset and Data Dictionary - 2018 Item # Item Name CDRI NPCR COC Reference SectionSEER

10 Record Type NAACCRR . Record ID.

20 Patient ID Number NAACCRR . Record IDR

21 Patient System ID‐Hosp NAACCR. . Record ID.

30 Registry Type NAACCR. . Record ID.

37 Reserved 00 Record ID

40 Registry ID NAACCRR . Record IDR

45 NPI‐‐Registry ID NAACCR; CMS; STORE. . Record IDR*

50 NAACCR Record Version NAACCRR . Record IDR

60 Tumor Record Number NAACCR. . Record IDS

70 Addr at DX‐‐City NAACCR; STORER R DemographicR

80 Addr at DX‐‐State NAACCR; STORER R DemographicR

81 State at DX Geocode 1970/80/90 NAACCRD . DemographicR

82 State at DX Geocode 2000 NAACCRD . DemographicR

83 State at DX Geocode 2010 NAACCRD . DemographicR*

84 State at DX Geocode 2020 NAACCRD . Demographic.

89 County at DX Analysis NAACCRD . DemographicR

90 County at DX Reported NAACCR; STORER R DemographicR

94 County at DX Geocode 1970/80/90 NAACCRD . DemographicD

95 County at DX Geocode2000 NAACCRD . DemographicD

96 County at DX Geocode2010 NAACCRD . DemographicD

97 County at DX Geocode2020 NAACCRD . Demographic.

Item # Item Name CDRI NPCR COC Reference SectionSEER

100 Addr at DX‐‐Postal Code NAACCR; STORER R DemographicR

102 Addr at DX‐‐Country NAACCR. R DemographicR

110 Census Tract 1970/80/90 NAACCR; U.S. Census Bureau Area ClassificationRH* . DemographicRH

120 Census Cod Sys 1970/80/90 NAACCR;RH* . DemographicRH

125 Census Tract 2020 NAACCRD . DemographicR*

130 Census Tract 2000 NAACCR; U.S. Census Bureau Area ClassificationRH . DemographicRH

135 Census Tract 2010 NAACCR; U.S. Census Bureau Area ClassificationR . DemographicR

145 Census Tr Poverty Indictr NAACCRR . DemographicD

150 Marital Status at DX NAACCR. . DemographicR

160 Race 1 NAACCR; STORER R DemographicR





170 Race Coding Sys‐‐Current NAACCR. R Demographic.

180 Race Coding Sys‐‐Original NAACCR. R Demographic.

190 Spanish/Hispanic Origin NAACCR; STORER R DemographicR

191 NHIA Derived Hisp Origin NAACCRD . DemographicD

192 IHS Link NAACCRR* . Demographic.

193 Race‐‐NAPIIA(derived API) NAACCRR . DemographicD

200 Computed Ethnicity SEERR . DemographicD

210 Computed Ethnicity Source SEERR . DemographicR


220 Sex NAACCR; STORER R DemographicR

230 Age at Diagnosis NAACCR; STORER R DemographicR

240 Date of Birth NAACCR; STORER R DemographicR

241 Date of Birth Flag NAACCR; STORER R DemographicR

250 Birthplace NAACCR; STORERH* . Demographic.

252 Birthplace‐‐State NAACCR; STORER* R DemographicR

254 Birthplace‐‐Country NAACCR; STORER* R DemographicR

270 Census Occ Code 1970‐2000 NAACCRR* . Demographic.

272 Census Ind Code 2010 CDC NAACCRR* . Demographic.

280 Census Ind Code 1970‐2000 NAACCRR* . Demographic.

282 Census Occ Code 2010 CDC NAACCRR* . Demographic.

290 Occupation Source NAACCRR* . Demographic.

300 Industry Source NAACCRR* . Demographic.

310 Text‐‐Usual Occupation NAACCRR* . Demographic.

320 Text‐‐Usual Industry NAACCRR* . Demographic.

330 Census Occ/Ind Sys 70‐00 NAACCRR* . Demographic.

339 RUCA 2000 NAACCRD . DemographicD

341 RUCA 2010 NAACCRD . DemographicD

345 URIC 2000 NAACCRD . DemographicD

346 URIC 2010 NAACCRD . DemographicD

351 GeoLocationID ‐ 1970/80/90 NAACCRD . DemographicR

352 GeoLocationID ‐ 2000 NAACCRD . DemographicR


353 GeoLocationID ‐ 2010 NAACCRD . DemographicR

354 GeoLocationID ‐ 2020 NAACCRD . Demographic.

361 Census Block Group 2020 Census. . Demographic.

362 Census Block Group 2000 NAACCR. . DemographicS

363 Census Block Group 2010 NAACCR. . DemographicR

364 Census Tr Cert 1970/80/90 NAACCRRH* . DemographicRH

365 Census Tr Certainty 2000 NAACCRRH . DemographicRH

366 GIS Coordinate Quality NAACCR,R* . DemographicS

367 Census Tr Certainty 2010 NAACCRR . DemographicR

368 Census Block Grp 1970/80/90 NAACCR; CENSUS. . DemographicS

369 Census Tract Certainty 2020 NAACCRD . Demographic.

370 Reserved 01 Record ID

380 Sequence Number‐‐Central NAACCRR . Cancer IdentificationR

390 Date of Diagnosis NAACCR; STORER R Cancer IdentificationR

391 Date of Diagnosis Flag NAACCR; STORER . Cancer IdentificationR

400 Primary Site NAACCR; STORE; ICD‐O‐3R R Cancer IdentificationR

410 Laterality NAACCR; STORER R Cancer IdentificationR

419 Morph‐‐Type&Behav ICD‐O‐2 NAACCR; ICD‐O‐2. . Cancer Identification.

420 Histology (92‐00) ICD‐O‐2 NAACCR; ICD‐O‐2RH RH Cancer IdentificationRH

430 Behavior (92‐00) ICD‐O‐2 NAACCR; ICD‐O‐2RH RH Cancer IdentificationRH

439 Date of Mult Tumors Flag NAACCR; STORE. RH Cancer IdentificationRH

440 Grade NAACCR; STORE; ICD‐0‐3RH RH Cancer IdentificationRH


441 Grade Path Value NAACCR; STORERH* RH Cancer IdentificationRH

442 Ambiguous Terminology DX NAACCR; STORE. RH Cancer IdentificationRH

443 Date Conclusive DX NAACCR; STORE. RH Cancer IdentificationRH

444 Mult Tum Rpt as One Prim NAACCR; STORE. RH Cancer IdentificationRH

445 Date of Mult Tumors NAACCR; STORE. RH Cancer IdentificationRH

446 Multiplicity Counter NAACCR; STORE. RH Cancer IdentificationRH

448 Date Conclusive DX Flag NAACCR; STORE. RH Cancer IdentificationRH

449 Grade Path System NAACCRRH* RH Cancer IdentificationRH

450 Site Coding Sys‐‐Current NAACCRR R Cancer Identification.

460 Site Coding Sys‐‐Original NAACCR. R Cancer Identification.

470 Morph Coding Sys‐‐Current NAACCRR R Cancer Identification.

480 Morph Coding Sys‐‐Originl NAACCR. R Cancer Identification.

490 Diagnostic Confirmation NAACCR; STORER R Cancer IdentificationR

500 Type of Reporting Source NAACCRR . Cancer IdentificationR

501 Casefinding Source NAACCRR* . Cancer Identification.

521 Morph‐‐Type&Behav ICD‐O‐3 NAACCR. . Cancer Identification.

522 Histologic Type ICD‐O‐3 NAACCR; STORE; ICD‐0‐3R R Cancer IdentificationR

523 Behavior Code ICD‐O‐3 NAACCR; STORE; ICD‐0‐3R R Cancer IdentificationR

530 Reserved 02 Demographic

540 Reporting Facility NAACCR; STORER R Hospital‐SpecificR

545 NPI‐‐Reporting Facility NAACCR; CMS; STORER* R Hospital‐SpecificR*

550 Accession Number‐‐Hosp NAACCR; STORE. R Hospital‐SpecificR


560 Sequence Number‐‐Hospital NAACCR; FRDS. R Hospital‐SpecificR

570 Abstracted By NAACCR; STORE. R Hospital‐SpecificR

580 Date of 1st Contact NAACCR; STORER R Hospital‐Specific.

581 Date of 1st Contact Flag NAACCRR R Hospital‐Specific.

590 Date of Inpt Adm NAACCR ‐ No‐longer supported by CoC Jan 2003. . Hospital‐Specific.

591 Date of Inpt Adm Flag NAACCR. . Hospital‐Specific.

600 Date of Inpt Disch NAACCR ‐ No longer supported by CoC Jan 2003. . Hospital‐Specific.

601 Date of Inpt Disch Flag NAACCR. . Hospital‐Specific.

605 Inpatient Status NAACCR. . Hospital‐Specific.

610 Class of Case NAACCR,; STORER R Hospital‐SpecificRC

630 Primary Payer at DX NAACCR; STORER* R Hospital‐SpecificR

668 RX Hosp‐‐Surg App 2010 NAACCR; STORE. R Hospital‐Specific.

670 RX Hosp‐‐Surg Prim Site NAACCR; STORE. R Hospital‐SpecificR

672 RX Hosp‐‐Scope Reg LN Sur NAACCR; STORE. R Hospital‐SpecificR

674 RX Hosp‐‐Surg Oth Reg/Dis NAACCR; STORE. R Hospital‐SpecificR

676 RX Hosp‐‐Reg LN Removed NAACCR; STORE. RH Hospital‐Specific.

680 Reserved 03 Cancer Identification

682 Date Regional Lymph Node Dissection NAACCR. R Stage/Prognostic FactRC

683 Date Regional Lymph Node Dissection NAACCR. R Stage/Prognostic FactRC

690 RX Hosp‐‐Radiation NAACCR. . Hospital‐SpecificRH

700 RX Hosp‐‐Chemo NAACCR; STORE. R Hospital‐SpecificR

710 RX Hosp‐‐Hormone NAACCR; STORE. R Hospital‐SpecificR


720 RX Hosp‐‐BRM NAACCR; STORE. R Hospital‐SpecificR

730 RX Hosp‐‐Other NAACCR; STORE. R Hospital‐SpecificR

740 RX Hosp‐‐DX/Stg Proc NAACCR; STORE. R Hospital‐Specific.

746 RX Hosp‐‐Surg Site 98‐02 NAACCR; ROADS. RH Hospital‐SpecificRH

747 RX Hosp‐‐Scope Reg 98‐02 NAACCR; ROADS. RH Hospital‐SpecificRH

748 RX Hosp‐‐Surg Oth 98‐02 NAACCR; ROADS. RH Hospital‐SpecificRH

750 Reserved 04 Hospital‐Specific

752 Tumor Size Clinical SEER; NAACCR. . Stage/Prognostic FactR

754 Tumor Size Pathologic SEER; NAACCR. . Stage/Prognostic FactR

756 Tumor Size Summary NPCR/CoC; NACCR; STORER R Stage/Prognostic FactS

759 SEER Summary Stage 2000 NAACCR; Summary Staging Manual 2000RH RH Stage/Prognostic FactRH

760 SEER Summary Stage 1977 NAACCR; Summary Staging Manual 1977RH RH Stage/Prognostic Fact.

762 Derived Summary Stage 2018 SEER; Not Available; NAACCR. . Stage/Prognostic FactD

764 Summary Stage 2018 SEER; Not Available; NAACCRR R Stage/Prognostic FactR*

772 EOD Primary Tumor SEER; NAACCR. . Stage/Prognostic FactR

774 EOD Regional Nodes SEER; NAACCR. . Stage/Prognostic FactR

776 EOD Mets SEER; NAACCR. . Stage/Prognostic FactR

779 Extent of Disease 10‐Dig SEER. . Stage/Prognostic Fact.

780 EOD‐‐Tumor Size SEER. RH Stage/Prognostic FactRH

785 Derived EOD 2018 T SEER. . Stage/Prognostic FactD

790 EOD‐‐Extension SEER. . Stage/Prognostic FactRH

795 Derived EOD 2018 M SEER. . Stage/Prognostic FactD


800 EOD‐‐Extension Prost Path SEER. . Stage/Prognostic FactRH

810 EOD‐‐Lymph Node Involv SEER. . Stage/Prognostic FactRH

815 Derived EOD 2018 N SEER. . Stage/Prognostic FactD

818 Derived EOD 2018 Stage Group SEER. . Stage/Prognostic FactD

820 Regional Nodes Positive NAACCR; STORER R Stage/Prognostic FactR

830 Regional Nodes Examined NAACCR; STORER R Stage/Prognostic FactR

832 Date of Sentinel Lymph Node Biopsy CoC. RS Stage/Prognostic FactR*

833 Date of Sentinel Lymph Node Biopsy Fl CoC. RS Stage/Prognostic FactR*

834 Sentinel Lymph Nodes Examined CoC. RS Stage/Prognostic FactR*

835 Sentinel Lymph Nodes Positive CoC. RS Stage/Prognostic FactR*

840 EOD‐‐Old 13 Digit SEER. . Stage/Prognostic FactRH



870 Coding System for EOD SEER. . Stage/Prognostic FactRH

880 TNM Path T NAACCR; STORE; AJCC Cancer Staging Manual 7th Ed.RH RH Stage/Prognostic FactRH

890 TNM Path N NAACCR; STORE; AJCC Cancer Staging Manual 7th Ed.RH RH Stage/Prognostic FactRH

900 TNM Path M NAACCR; STORE; AJCC Cancer Staging Manual 7th Ed.RH RH Stage/Prognostic FactRH

910 TNM Path Stage Group NAACCR; STORE; AJCC Cancer Staging Manual 7th Ed.RH RH Stage/Prognostic FactRH*

920 TNM Path Descriptor NAACCR; STORE; AJCC Cancer Staging Manual 7th Ed.RH RH Stage/Prognostic FactRH

930 TNM Path Staged By NAACCR; STORE. RH Stage/Prognostic FactRH

940 TNM Clin T NAACCR; STORE; AJCC Cancer Staging Manual 7th Ed.RH RH Stage/Prognostic FactRH

950 TNM Clin N NAACCR; STORE; AJCC Cancer Staging Manual 7th Ed.RH RH Stage/Prognostic FactRH


960 TNM Clin M NAACCR; STORE; AJCC Cancer Staging Manual 7th Ed.RH RH Stage/Prognostic FactRH

970 TNM Clin Stage Group NAACCR; STORE; AJCC Cancer Staging Manual 7th Ed.RH RH Stage/Prognostic FactRH*

980 TNM Clin Descriptor NAACCR; STORE; AJCC Cancer Staging Manual 7th Ed.RH RH Stage/Prognostic FactRH

990 TNM Clin Staged By NAACCR; STORE. RH Stage/Prognostic FactRH

995 AJCC ID NAACCRD D Stage/Prognostic FactRC

1001 AJCC TNM Clin T AJCC. R Stage/Prognostic FactRC

1002 AJCC TNM Clin N AJCC. R Stage/Prognostic FactRC

1003 AJCC TNM Clin M AJCC. R Stage/Prognostic FactRC

1004 AJCC TNM Clin Stage Group AJCC. R Stage/Prognostic FactRC

1011 AJCC TNM Path T AJCC. R Stage/Prognostic FactRC

1012 AJCC TNM Path N AJCC. R Stage/Prognostic FactRC

1013 AJCC TNM Path M AJCC. R Stage/Prognostic FactRC

1014 AJCC TNM Path Stage Group AJCC. R Stage/Prognostic FactRC

1021 AJCC TNM Post Therapy T AJCC. R Stage/Prognostic FactRC

1022 AJCC TNM Post Therapy N AJCC. R Stage/Prognostic FactRC

1023 AJCC TNM Post Therapy M AJCC. R Stage/Prognostic FactRC

1024 AJCC TNM Post Therapy Stage Group AJCC. R Stage/Prognostic FactRC

1030 AJCC TNM Clin T Suffix Retired ‐ V11 Jan 2006 Not Known

1031 AJCC TNM Clin T Suffix AJCC. R Stage/Prognostic FactRC

1032 AJCC TNM Path T Suffix AJCC. R Stage/Prognostic FactRC

1033 AJCC TNM Post Therapy T Suffix AJCC. R Stage/Prognostic FactRC

1034 AJCC TNM Clin N Suffix AJCC. R Stage/Prognostic FactRC


1035 AJCC TNM Path N Suffix AJCC. R Stage/Prognostic FactRC

1036 AJCC TNM Post Therapy N Suffix AJCC. R Stage/Prognostic FactRC

1060 TNM Edition Number NAACCR; STORERH R Stage/Prognostic FactRH

1112 Mets at DX‐Bone SEER; NAACCR; STORE. R Stage/Prognostic FactR

1113 Mets at DX‐Brain SEER; NAACCR; STORE. R Stage/Prognostic FactR

1114 Mets at Dx‐Distant LN SEER; NAACCR; STORE. R Stage/Prognostic FactR

1115 Mets at DX‐Liver SEER; NAACCR; STORE. R Stage/Prognostic FactR

1116 Mets at DX‐Lung SEER; NAACCR; STORE. R Stage/Prognostic FactR

1117 Mets at DX‐Other SEER; NAACCR; STORE. R Stage/Prognostic FactR

1120 Pediatric Stage NAACCR ‐ No longer supported by CoC Jan 2003. . Stage/Prognostic Fact.

1130 Pediatric Staging System NAACCR ‐ No longer supported by CoC Jan 2003. . Stage/Prognostic Fact.

1140 Pediatric Staged By NAACCR ‐ No longer supported by CoC Jan 2003. . Stage/Prognostic Fact.

1150 Tumor Marker 1 NAACCR; SEER ‐ No longer required or recommended . RH Stage/Prognostic FactRH



1180 Reserved 05 Stage/Prognostic Fact

1182 Lymphovascular Invasion NAACCR; STORER* R Stage/Prognostic FactRS

1190 Reserved 06 Treatment‐1st Cours

1200 RX Date Surgery NAACCR; STORER R Treatment‐1st CoursRC

1201 RX Date Surgery Flag NAACCR; STORER R Treatment‐1st CoursRC

1210 RX Date Radiation NAACCR; STORER R Treatment‐1st CoursRC

1211 RX Date Radiation Flag NAACCR; STORER R Treatment‐1st CoursRC


1220 RX Date Chemo NAACCR; STORER R Treatment‐1st CoursRC

1221 RX Date Chemo Flag NAACCR; STORER R Treatment‐1st CoursRC

1230 RX Date Hormone NAACCR; STORER R Treatment‐1st CoursRC

1231 RX Date Hormone Flag NAACCR; STORER R Treatment‐1st CoursRC

1240 RX Date BRM NAACCR; STORER R Treatment‐1st CoursRC

1241 RX Date BRM Flag NAACCR; STORER R Treatment‐1st CoursRC

1250 RX Date Other NAACCR; STORER R Treatment‐1st CoursRC

1251 RX Date Other Flag NAACCR; STORER R Treatment‐1st CoursRC

1260 Date Initial RX SEER NAACCR; SEERR# . Treatment‐1st CoursR

1261 Date Initial RX SEER Flag NAACCRR# . Treatment‐1st CoursR

1270 Date 1st Crs RX CoC NAACCR; STORER# R Treatment‐1st Cours.

1271 Date 1st Crs RX CoC Flag NAACCRR# R Treatment‐1st Cours.

1280 RX Date DX/Stg Proc NAACCR; STORE. R Treatment‐1st Cours.

1281 RX Date DX/Stg Proc Flag NAACCR; STORE. R Treatment‐1st Cours.

1285 RX Summ‐‐Treatment Status NAACCR; STORER# R Treatment‐1st CoursR

1290 RX Summ‐‐Surg Prim Site NAACCR; STORE ‐ Appendix BR R Treatment‐1st CoursR

1292 RX Summ‐‐Scope Reg LN Sur NAACCR; STORER R Treatment‐1st CoursR

1294 RX Summ‐‐Surg Oth Reg/Dis NAACCR; STORER R Treatment‐1st CoursR

1296 RX Summ‐‐Reg LN Examined NAACCR ‐ No longer supported by CoC Jan 2003. RH Treatment‐1st CoursRH

1300 Reserved 07 Treatment‐Subseque

1310 RX Summ‐‐Surgical Approch NAACCR ‐ No longer supported by CoC Jan 2003. RH Treatment‐1st Cours.

1320 RX Summ‐‐Surgical Margins NAACCR; STORE. R Treatment‐1st CoursR*


1330 RX Summ‐‐Reconstruct 1st NAACCR ‐ No longer supported by CoC Jan 2003. RH Treatment‐1st CoursRH

1340 Reason for No Surgery NAACCR; STORER R Treatment‐1st CoursR

1350 RX Summ‐‐DX/Stg Proc NAACCR; STORE. R Treatment‐1st Cours.

1360 RX Summ‐‐Radiation NAACCRRH . Treatment‐1st CoursRH

1370 RX Summ‐‐Rad to CNS NAACCR ‐ No longer collected by CoC 1996 cases. . Treatment‐1st CoursRH

1380 RX Summ‐‐Surg/Rad Seq NAACCR; STORER R Treatment‐1st CoursR

1390 RX Summ‐‐Chemo NAACCR; STORER R Treatment‐1st CoursR

1400 RX Summ‐‐Hormone NAACCR; STORER R Treatment‐1st CoursR

1410 RX Summ‐‐BRM NAACCR; STORER R Treatment‐1st CoursR

1420 RX Summ‐‐Other NAACCR; STORER R Treatment‐1st CoursR

1430 Reason for No Radiation NAACCR; STORER R Treatment‐1st CoursR

1460 RX Coding System‐‐Current NAACCRR R Treatment‐1st Cours.

1501 Phase I Dose per Fraction CoC. R Treatment‐1st CoursR*

1502 Phase I Radiation External Beam Plann CoC. R Treatment‐1st CoursRC

1503 Phase I Number of Fractions CoC. R Treatment‐1st CoursR*

1504 Phase I Radiation Primary Treatment CoC. R Treatment‐1st CoursR*

1505 Phase I Radiation to Draining Lymph N CoC. R Treatment‐1st CoursR*

1506 Phase I Radiation Treatment Modality CoCR R Treatment‐1st CoursR

1507 Phase I Total Dose CoC. R Treatment‐1st CoursR*

1510 Rad‐‐Regional Dose: cGy NAACCR; STORE. . Treatment‐1st Cours.

1511 Phase II Dose per Fraction CoC. R Treatment‐1st CoursR*

1512 Phase II Radiation External Beam Plan CoC. R Treatment‐1st CoursRC


1513 Phase II Number of Fractions CoC. R Treatment‐1st CoursR*

1514 Phase II Radiation Primary Treatment CoC. R Treatment‐1st CoursR*

1515 Phase II Radiation to Draining Lymph CoC. R Treatment‐1st CoursR*

1516 Phase II Radiation Treatment Modality CoC. R Treatment‐1st CoursR

1517 Phase II Total Dose CoC. R Treatment‐1st CoursR*

1520 Rad‐‐No of Treatment Vol NAACCR; STORE. . Treatment‐1st Cours.

1521 Phase III Dose per Fraction CoC. R Treatment‐1st CoursR*

1522 Phase III Radiation External Beam Plan CoC. R Treatment‐1st CoursRC

1523 Phase III Number of Fractions CoC. R Treatment‐1st CoursR*

1524 Phase III Radiation Primary Treatment CoC. R Treatment‐1st CoursR*

1525 Phase III Radiation to Draining Lymph CoC. R Treatment‐1st CoursR*

1526 Phase III Radiation Treatment Modalit CoC. R Treatment‐1st CoursR

1527 Phase III Total Dose CoC. R Treatment‐1st CoursR*

1531 Radiation Treatment Discontinued Ear CoC. R Treatment‐1st CoursR*

1532 Number of Phases of Rad Treatment t CoC. R Treatment‐1st CoursR*

1533 Total Dose CoC. R Treatment‐1st CoursR*

1540 Rad‐‐Treatment Volume NAACCR; STORE. . Treatment‐1st Cours.

1550 Rad‐‐Location of RX NAACCR; STORE. R Treatment‐1st Cours.

1570 Rad‐‐Regional RX Modality NAACCR; STORERH . Treatment‐1st Cours.

1639 RX Summ‐‐Systemic/Sur Seq NAACCR; STORER R Treatment‐1st CoursR

1640 RX Summ‐‐Surgery Type NAACCR;SEER. . Treatment‐1st CoursRH

1646 RX Summ‐‐Surg Site 98‐02 NAACCR; ROADS. RH Treatment‐1st CoursRH


1647 RX Summ‐‐Scope Reg 98‐02 NAACCR; ROADS. RH Treatment‐1st CoursRH

1648 RX Summ‐‐Surg Oth 98‐02 NAACCR; ROADS. RH Treatment‐1st CoursRH

1650 Reserved 08 Edit Overrides/Conve

1660 Subsq RX 2nd Course Date CER ‐ As available: Breast, Colorectal, CML. . Treatment‐Subseque.

1661 Subsq RX 2ndCrs Date Flag CER ‐ As available: Breast, Colorectal, CML. . Treatment‐Subseque.

1670 Subsq RX 2nd Course Codes NAACCR ‐ No longer supported by CoC Jan 2003. . Treatment‐Subseque.

1671 Subsq RX 2nd Course Surg CER ‐ As available: Breast, Colorectal, CML. . Treatment‐Subseque.

1672 Subsq RX 2nd Course Rad CER ‐ As available: Breast, Colorectal, CML. . Treatment‐Subseque.

1673 Subsq RX 2nd Course Chemo CER ‐ As available: Breast, Colorectal, CML. . Treatment‐Subseque.

1674 Subsq RX 2nd Course Horm CER ‐ As available: Breast, Colorectal, CML. . Treatment‐Subseque.

1675 Subsq RX 2nd Course BRM CER ‐ As available: Breast, Colorectal, CML. . Treatment‐Subseque.

1676 Subsq RX 2nd Course Oth CER ‐ As available: Breast, Colorectal, CML. . Treatment‐Subseque.

1677 Subsq RX 2nd‐‐Scope LN SU NAACCR ‐ No longer supported by CoC Jan 2003. . Treatment‐Subseque.

1678 Subsq RX 2nd‐‐Surg Oth NAACCR ‐ No longer supported by CoC Jan 2003. . Treatment‐Subseque.

1679 Subsq RX 2nd‐‐Reg LN Rem NAACCR ‐ No longer supported by CoC Jan 2003. . Treatment‐Subseque.

1680 Subsq RX 3rd Course Date NAACCR ‐ No longer supported by CoC Jan 2003. . Treatment‐Subseque.

1681 Subsq RX 3rdCrs Date Flag NAACCR. . Treatment‐Subseque.

1690 Subsq RX 3rd Course Codes NAACCR ‐ No longer supported by CoC Jan 2003. . Treatment‐Subseque.

1691 Subsq RX 3rd Course Surg NAACCR ‐ No longer supported by CoC Jan 2003. . Treatment‐Subseque.

1692 Subsq RX 3rd Course Rad NAACCR ‐ No longer supported by CoC Jan 2003. . Treatment‐Subseque.

1693 Subsq RX 3rd Course Chemo NAACCR ‐ No longer supported by CoC Jan 2003. . Treatment‐Subseque.

1694 Subsq RX 3rd Course Horm NAACCR ‐ No longer supported by CoC Jan 2003. . Treatment‐Subseque.


1695 Subsq RX 3rd Course BRM NAACCR ‐ No longer supported by CoC Jan 2003. . Treatment‐Subseque.

1696 Subsq RX 3rd Course Oth NAACCR ‐ No longer supported by CoC Jan 2003. . Treatment‐Subseque.

1697 Subsq RX 3rd‐‐Scope LN Su NAACCR ‐ No longer supported by CoC Jan 2003. . Treatment‐Subseque.

1698 Subsq RX 3rd‐‐Surg Oth NAACCR ‐ No longer supported by CoC Jan 2003. . Treatment‐Subseque.

1699 Subsq RX 3rd‐‐Reg LN Rem NAACCR ‐ No longer supported by CoC Jan 2003. . Treatment‐Subseque.

1700 Subsq RX 4th Course Date NAACCR ‐ No longer supported by CoC Jan 2003. . Treatment‐Subseque.

1701 Subsq RX 4thCrs Date Flag NAACCR. . Treatment‐Subseque.

1710 Subsq RX 4th Course Codes NAACCR ‐ No longer supported by CoC Jan 2003. . Treatment‐Subseque.

1711 Subsq RX 4th Course Surg NAACCR ‐ No longer supported by CoC Jan 2003. . Treatment‐Subseque.

1712 Subsq RX 4th Course Rad NAACCR ‐ No longer supported by CoC Jan 2003. . Treatment‐Subseque.

1713 Subsq RX 4th Course Chemo NAACCR ‐ No longer supported by CoC Jan 2003. . Treatment‐Subseque.

1714 Subsq RX 4th Course Horm NAACCR ‐ No longer supported by CoC Jan 2003. . Treatment‐Subseque.

1715 Subsq RX 4th Course BRM NAACCR ‐ No longer supported by CoC Jan 2003. . Treatment‐Subseque.

1716 Subsq RX 4th Course Oth NAACCR ‐ No longer supported by CoC Jan 2003. . Treatment‐Subseque.

1717 Subsq RX 4th‐‐Scope LN Su NAACCR ‐ No longer supported by CoC Jan 2003. . Treatment‐Subseque.

1718 Subsq RX 4th‐‐Surg Oth NAACCR ‐ No longer supported by CoC Jan 2003. . Treatment‐Subseque.

1719 Subsq RX 4th‐‐Reg LN Rem NAACCR ‐ No longer supported by CoC Jan 2003. . Treatment‐Subseque.

1740 Reserved 09 Follow‐up/Recurrenc

1741 Subsq RX‐‐Reconstruct Del NAACCR ‐ No longer supported by CoC Jan 2003. . Treatment‐Subseque.

1750 Date of Last Contact NAACCR; STORER R Follow‐up/RecurrencR

1751 Date of Last Contact Flag NAACCR; STORER R Follow‐up/RecurrencR

1755 Date of Death‐‐Canada NAACCR; CCCR. . Follow‐up/Recurrenc.


1756 Date of Death‐‐CanadaFlag NAACCR; CCCR. . Follow‐up/Recurrenc.

1760 Vital Status NAACCR; STORER R Follow‐up/RecurrencR

1762 Vital Status Recode NAACCRD . Follow‐up/RecurrencD

1770 Cancer Status NAACCR; STORE. R Follow‐up/Recurrenc.

1772 Date of Last Cancer (tumor) Status CoC. R Follow‐up/Recurrenc.

1773 Date of Last Cancer (tumor) Status Fla CoCR Follow‐up/Recurrenc.

1775 Record Number Recode NAACCR. . Follow‐up/RecurrencD

1780 Quality of Survival NAACCR ‐ No longer supported by CoC Jan 2003. . Follow‐up/Recurrenc.

1782 Surv‐Date Active Followup NAACCR. . Follow‐up/RecurrencD

1783 Surv‐Flag Active Followup NAACCR. . Follow‐up/RecurrencD

1784 Surv‐Mos Active Followup NAACCR. . Follow‐up/RecurrencD

1785 Surv‐Date Presumed Alive NAACCRD . Follow‐up/RecurrencD

1786 Surv‐Flag Presumed Alive NAACCRD . Follow‐up/RecurrencD

1787 Surv‐Mos Presumed Alive NAACCRD . Follow‐up/RecurrencD

1788 Surv‐Date DX Recode NAACCRD . Follow‐up/RecurrencD

1790 Follow‐Up Source NAACCR; STORER* R Follow‐up/Recurrenc.

1791 Follow‐up Source Central NAACCRR . Follow‐up/Recurrenc.

1800 Next Follow‐Up Source NAACCR; STORE. R Follow‐up/Recurrenc.

1810 Addr Current‐‐City NAACCR; STORE. R Follow‐up/RecurrencR

1820 Addr Current‐‐State NAACCR; STORE. R Follow‐up/RecurrencR

1830 Addr Current‐‐Postal Code NAACCR; STORE. R Follow‐up/RecurrencR

1832 Addr Current‐‐Country NAACCR; STORE. R DemographicR


1835 Reserved 10 Patient‐Confidential

1840 County‐‐Current NAACCR ‐ No longer supported by CoC Jan 2003. . Follow‐up/Recurrenc.

1842 Follow‐Up Contact‐‐City NAACCR; SEER. . Follow‐up/Recurrenc.

1844 Follow‐Up Contact‐‐State NAACCR; SEER. . Follow‐up/Recurrenc.

1846 Follow‐Up Contact‐‐Postal NAACCR; SEER. . Follow‐up/Recurrenc.

1847 FollowUp Contact‐‐Country NAACCR. . Demographic.

1850 Unusual Follow‐Up Method NAACCR ‐ No longer supported by CoC Jan 2003. . Follow‐up/Recurrenc.

1860 Recurrence Date‐‐1st NAACCR; STORE. R Follow‐up/RecurrencRC

1861 Recurrence Date‐‐1st Flag NAACCR; STORE. R Follow‐up/RecurrencRC

1880 Recurrence Type‐‐1st NAACCR; STORE. R Follow‐up/RecurrencRC

1900 Reserved 11 Hospital‐Confidential

1910 Cause of Death NAACCR; ROADS ‐ No‐longer supported by CoC Jan 20R . Follow‐up/RecurrencR

1914 SEER Cause Specific COD SEERD . Follow‐up/RecurrencD

1915 SEER Other COD SEERD . Follow‐up/RecurrencD

1920 ICD Revision Number NAACCR; SEERR . Follow‐up/RecurrencR

1930 Autopsy NAACCR; ROADS ‐ No‐longer supported by CoC Jan 20. . Follow‐up/Recurrenc.

1940 Place of Death NAACCRRH . Follow‐up/Recurrenc.

1942 Place of Death‐‐State NAACCRR . DemographicR

1944 Place of Death‐‐Country NAACCRR* . DemographicR

1960 Site (73‐91) ICD‐O‐1 NAACCR; ICD‐O‐1. . Edit Overrides/ConveRH

1970 Morph (73‐91) ICD‐O‐1 NAACCR; ICD‐O‐1. . Edit Overrides/Conve.

1971 Histology (73‐91) ICD‐O‐1 NAACCR; ICD‐O‐1. . Edit Overrides/ConveRH


1972 Behavior (73‐91) ICD‐O‐1 NAACCR; ICD‐O‐1. . Edit Overrides/ConveRH

1973 Grade (73‐91) ICD‐O‐1 NAACCR; ICD‐O‐1. . Edit Overrides/ConveRH

1980 ICD‐O‐2 Conversion Flag NAACCR; SEER; STORE. RH Edit Overrides/ConveR

1981 Over‐ride SS/NodesPos NAACCR. . Edit Overrides/ConveRH

1982 Over‐ride SS/TNM‐N NAACCR. . Edit Overrides/ConveRH

1983 Over‐ride SS/TNM‐M NAACCR. . Edit Overrides/ConveRH

1985 Over‐ride Acsn/Class/Seq NAACCR; STORE. R Edit Overrides/Conve.

1986 Over‐ride HospSeq/DxConf NAACCR; STORE. R Edit Overrides/Conve.

1987 Over‐ride CoC‐Site/Type NAACCR; STORE. R Edit Overrides/Conve.

1988 Over‐ride HospSeq/Site NAACCR; STORE. R Edit Overrides/Conve.

1989 Over‐ride Site/TNM‐StgGrp NAACCR; STORER R Edit Overrides/ConveR

1990 Over‐ride Age/Site/Morph NAACCR; STORER R Edit Overrides/ConveR

1992 Over‐ride TNM Stage NAACCRR . Edit Overrides/Conve.

1993 Over‐ride TNM Tis NAACCRR . Edit Overrides/ConveR

1994 Over‐ride TNM 3 NAACCR. . Edit Overrides/Conve.

2000 Over‐ride SeqNo/DxConf NAACCRR . Edit Overrides/ConveR

2010 Over‐ride Site/Lat/SeqNo NAACCRR . Edit Overrides/ConveR

2020 Over‐ride Surg/DxConf NAACCR; STORER R Edit Overrides/ConveR

2030 Over‐ride Site/Type NAACCR; STORER R Edit Overrides/ConveR

2040 Over‐ride Histology NAACCR; STORER R Edit Overrides/ConveR

2050 Over‐ride Report Source NAACCRR . Edit Overrides/ConveR

2060 Over‐ride Ill‐define Site NAACCRR . Edit Overrides/ConveR


2070 Over‐ride Leuk Lymphoma NAACCR; STORER R Edit Overrides/ConveR

2071 Over‐ride Site/Behavior NAACCR; STORER R Edit Overrides/ConveR

2072 Over‐ride Site/EOD/DX Dt NAACCR. . Edit Overrides/ConveR

2073 Over‐ride Site/Lat/EOD NAACCR. . Edit Overrides/ConveR

2074 Over‐ride Site/Lat/Morph NAACCR; STORER R Edit Overrides/ConveR

2078 Over‐ride Name/Sex NAACCRR . Edit Overrides/ConveR

2080 Reserved 13 Pathology

2081 CRC CHECKSUM NAACCR. . Edit Overrides/ConveS

2085 Date Case Initiated NAACCR. . Edit Overrides/Conve.

2090 Date Case Completed NAACCR. . Edit Overrides/Conve.

2092 Date Case Completed‐‐CoC NAACCR; STORE. D Edit Overrides/Conve.

2100 Date Case Last Changed NAACCR. D Edit Overrides/Conve.

2110 Date Case Report Exported NAACCR; NPCRR . Edit Overrides/Conve.

2111 Date Case Report Received NAACCR; NPCRR . Edit Overrides/Conve.

2112 Date Case Report Loaded NAACCR; NPCRR . Edit Overrides/Conve.

2113 Date Tumor Record Availbl NAACCR; NPCRR . Edit Overrides/Conve.

2116 ICD‐O‐3 Conversion Flag NAACCR; STORER . Edit Overrides/ConveR

2120 SEER Coding Sys‐‐Current NAACCR. . Edit Overrides/Conve.

2130 SEER Coding Sys‐‐Original NAACCR. . Edit Overrides/Conve.

2140 CoC Coding Sys‐‐Current NAACCR; STORE. R Edit Overrides/Conve.

2150 CoC Coding Sys‐‐Original NAACCR; STORE. R Edit Overrides/Conve.

2152 CoC Accredited Flag NPCRR . Edit Overrides/ConveR


2155 RQRS NCDB Submission Flag CoC. R Edit Overrides/Conve.

2161 Reserved 18 Not Known Treatment‐1st Cours

2162 Reserved 19 Not Known Stage/Prognostic Fact

2163 Reserved 20 Not Known Stage/Prognostic Fact

2170 Vendor Name NAACCR. R Edit Overrides/Conve.

2180 SEER Type of Follow‐Up NAACCR; SEER. . Edit Overrides/ConveR

2190 SEER Record Number NAACCR; SEER. . Edit Overrides/Conve.

2200 Diagnostic Proc 73‐87 NAACCR ‐ No longer collected SEER. . Edit Overrides/ConveRH

2210 Reserved 14 Text‐Miscellaneous

2220 State/Requestor Items NAACCR (Varies). . Special Use.

2230 Name‐‐Last NAACCR; STORER R Patient‐ConfidentialR

2240 Name‐‐First NAACCR; STORER R Patient‐ConfidentialR

2250 Name‐‐Middle NAACCR; STORER R Patient‐ConfidentialR

2260 Name‐‐Prefix NAACCR ‐ No longer supported by CoC Jan 2003. . Patient‐Confidential.

2270 Name‐‐Suffix NAACCR ‐ No longer supported by CoC Jan 2003. . Patient‐ConfidentialR

2280 Name‐‐Alias NAACCR; ROADS ‐ No‐longer supported by CoC Jan 20R . Patient‐ConfidentialR

2290 Name‐‐Spouse/Parent NAACCR. . Patient‐Confidential.

2300 Medical Record Number NAACCR; STORER R Patient‐ConfidentialR

2310 Military Record No Suffix NAACCR; STORE. . Patient‐Confidential.

2315 Medicare Beneficiary Identifier NAACCR Patient‐Confidential

2320 Social Security Number NAACCR; STORER R Patient‐ConfidentialR

2330 Addr at DX‐‐No & Street NAACCR; STORER R Patient‐ConfidentialR


2335 Addr at DX‐‐Supplementl NAACCR; STORER R* Patient‐ConfidentialR

2350 Addr Current‐‐No & Street NAACCR; STORE. R Patient‐ConfidentialR

2352 Latitude NAACCRR* . Patient‐ConfidentialS

2354 Longitude NAACCRR* . Patient‐ConfidentialS

2355 Addr Current‐‐Supplementl NAACCR; STORE. R* Patient‐ConfidentialR*

2360 Telephone NAACCR; STORE. R Patient‐ConfidentialR

2380 DC State File Number NAACCRR . Patient‐ConfidentialR*

2390 Name‐‐Maiden NAACCR; ROADS ‐ No‐longer supported by CoC Jan 20R . Patient‐ConfidentialR

2392 Follow‐Up Contact‐‐No&St NAACCR; SEER. . Patient‐Confidential.

2393 Follow‐Up Contact‐‐Suppl NAACCR; SEER. . Patient‐Confidential.

2394 Follow‐Up Contact‐‐Name NAACCR; SEER. . Patient‐Confidential.

2400 Reserved 15 Stage/Prognostic Fact

2410 Institution Referred From NAACCR; STORE. . Hospital‐Confidential.

2415 NPI‐‐Inst Referred From NAACCR; CMS; STORE. R Hospital‐Confidential.

2420 Institution Referred To NAACCR; STORE. . Hospital‐Confidential.

2425 NPI‐‐Inst Referred To NAACCR; CMS; STORE. R Hospital‐Confidential.

2440 Following Registry NAACCR; STORE. . Hospital‐ConfidentialRH

2445 NPI‐‐Following Registry NAACCR; CMS; STORE. . Hospital‐ConfidentialRH*

2450 Reserved 16 Demographic

2460 Physician‐‐Managing NAACCR; STORE. . Other‐Confidential.

2465 NPI‐‐Physician‐‐Managing NAACCR; CMS; STORE. R Other‐Confidential.

2470 Physician‐‐Follow‐Up NAACCR; STORE. . Other‐ConfidentialR


2475 NPI‐‐Physician‐‐Follow‐Up NAACCR; CMS; STORE. R Other‐ConfidentialR*

2480 Physician‐‐Primary Surg NAACCR; STORE. . Other‐Confidential.

2485 NPI‐‐Physician‐‐Primary Surg NAACCR; CMS; STORE. R Other‐Confidential.

2490 Physician 3 NAACCR; STORE. . Other‐Confidential.

2495 NPI‐‐Physician 3 NAACCR; CMS; STORE. R Other‐Confidential.

2500 Physician 4 NAACCR; STORE. . Other‐Confidential.

2505 NPI‐‐Physician 4 NAACCR; CMS; STORE. R Other‐Confidential.

2508 EHR Reporting NAACCR. . Other‐Confidential.

2510 Reserved 12 Other‐Confidential

2520 Text‐‐DX Proc‐‐PE NAACCR; NPCRR^ . Text‐DiagnosisR

2530 Text‐‐DX Proc‐‐X‐ray/Scan NAACCR; NPCRR^ . Text‐DiagnosisR

2540 Text‐‐DX Proc‐‐Scopes NAACCR; NPCRR^ . Text‐DiagnosisR

2550 Text‐‐DX Proc‐‐Lab Tests NAACCR; NPCRR^ . Text‐DiagnosisR

2560 Text‐‐DX Proc‐‐Op NAACCR; NPCRR^ . Text‐DiagnosisR

2570 Text‐‐DX Proc‐‐Path NAACCR; NPCRR^ . Text‐DiagnosisR

2580 Text‐‐Primary Site Title NAACCR; NPCRR^ . Text‐DiagnosisR

2590 Text‐‐Histology Title NAACCR; NPCRR^ . Text‐DiagnosisR

2600 Text‐‐Staging NAACCR; NPCRR^ . Text‐DiagnosisR

2610 RX Text‐‐Surgery NAACCR; NPCRR^ . Text‐TreatmentR

2620 RX Text‐‐Radiation (Beam) NAACCR; NPCRR^ . Text‐TreatmentR

2630 RX Text‐‐Radiation Other NAACCR; NPCRR^ . Text‐TreatmentR

2640 RX Text‐‐Chemo NAACCR; NPCRR^ . Text‐TreatmentR


2650 RX Text‐‐Hormone NAACCR; NPCRR^ . Text‐TreatmentR

2660 RX Text‐‐BRM NAACCR; NPCRR^ . Text‐TreatmentR

2670 RX Text‐‐Other NAACCR; NPCRR^ . Text‐TreatmentR

2680 Text‐‐Remarks NAACCR; NPCR. . Text‐MiscellaneousR

2690 Text‐‐Place of Diagnosis NAACCR; NPCR. . Text‐Miscellaneous.

2730 CS PreRx Tumor Size NAACCR; AJCC0 0 Not Known0

2735 CS PreRx Extension NAACCR; AJCC0 0 Not Known0

2740 CS PreRx Tum Sz/Ext Eval NAACCR; AJCC0 0 Not Known0

2750 CS PreRx Lymph Nodes NAACCR; AJCC0 0 Not Known0

2755 CS PreRx Reg Nodes Eval NAACCR; AJCC0 0 Not Known0

2760 CS PreRx Mets at DX NAACCR; AJCC0 0 Not Known0

2765 CS PreRx Mets Eval NAACCR; AJCC0 0 Not Known0

2770 CS PostRx Tumor Size NAACCR; AJCC0 0 Not Known0

2775 CS PostRx Extension NAACCR; AJCC0 0 Not Known0

2780 CS PostRx Lymph Nodes NAACCR; AJCC0 0 Not Known0

2785 CS PostRx Mets at DX NAACCR; AJCC0 0 Not Known0

2800 CS Tumor Size NAACCR; STORE; and CS ManualRH* RH Stage/Prognostic FactRH*

2810 CS Extension NAACCR; STORE; and CS ManualRH* RH Stage/Prognostic FactRH*

2820 CS Tumor Size/Ext Eval NAACCR; STORE; and CS ManualRH* RH Stage/Prognostic FactRH*

2830 CS Lymph Nodes NAACCR; STORE; and CS ManualRH* RH Stage/Prognostic FactRH*

2840 CS Lymph Nodes Eval NAACCR; STORE; and CS ManualRH* RH Stage/Prognostic FactRH*

2850 CS Mets at DX NAACCR; STORE; and CS ManualRH* RH Stage/Prognostic FactRH*


2851 CS Mets at Dx‐Bone NAACCR; STORE. RH Stage/Prognostic FactRH

2852 CS Mets at Dx‐Brain NAACCR; STORE. RH Stage/Prognostic FactRH

2853 CS Mets at Dx‐Liver NAACCR; STORE. RH Stage/Prognostic FactRH

2854 CS Mets at Dx‐Lung NAACCR; STORE. RH Stage/Prognostic FactRH

2860 CS Mets Eval NAACCR; STORE; and CS ManualRH* RH Stage/Prognostic FactRH*

2861 CS Site‐Specific Factor 7 NAACCR; STORERH* RH Stage/Prognostic FactRH



2864 CS Site‐Specific Factor10 NAACCR; STORERH* RH Stage/Prognostic FactRH








2872 CS Site‐Specific Factor18 NAACCR; STORE. RH Stage/Prognostic FactRH









2880 CS Site‐Specific Factor 1 NAACCR; STORE; and CS ManualRH* RH Stage/Prognostic FactRH






2935 CS Version Input Original NAACCR; STORER* RH Stage/Prognostic FactRH*

2936 CS Version Derived NAACCR; STORERH* DH Stage/Prognostic FactD*

2937 CS Version Input Current NAACCR; AJCC; STORER* RH Stage/Prognostic FactRH*

2940 Derived AJCC‐6 T NAACCR; STORE; and CS Manual. DH Stage/Prognostic FactDH

2950 Derived AJCC‐6 T Descript NAACCR; STORE; and CS Manual. DH Stage/Prognostic FactDH

2960 Derived AJCC‐6 N NAACCR; STORE; and CS Manual. DH Stage/Prognostic FactDH

2970 Derived AJCC‐6 N Descript NAACCR; STORE; and CS Manual. DH Stage/Prognostic FactDH

2980 Derived AJCC‐6 M NAACCR; STORE; and CS Manual. DH Stage/Prognostic FactDH

2990 Derived AJCC‐6 M Descript NAACCR; STORE; and CS Manual. DH Stage/Prognostic FactDH

3000 Derived AJCC‐6 Stage Grp NAACCR; STORE; and CS Manual. DH Stage/Prognostic FactDH

3010 Derived SS1977 NAACCR; STORE; and CS Manual. DH Stage/Prognostic FactD*

3020 Derived SS2000 NAACCR; STORE; and CS ManualRH* DH Stage/Prognostic FactD+

3030 Derived AJCC‐‐Flag NAACCR; STORE. DH Stage/Prognostic FactDH

3040 Derived SS1977‐‐Flag NAACCR; STORE. DH Stage/Prognostic FactD*


3050 Derived SS2000‐‐Flag NAACCR; STORERH* DH Stage/Prognostic FactD*

3100 Archive FIN NAACCR; STORE. R Hospital‐Specific.

3105 NPI‐‐Archive FIN NAACCR; CMS; STORE. R Hospital‐Specific.

3110 Comorbid/Complication 1 NAACCR; STORE ‐ Required for 2011 cases CER. RH Stage/Prognostic Fact.










3165 ICD Revision Comorbid NAACCR; STORE. . Stage/Prognostic Fact.

3170 RX Date Mst Defn Srg NAACCR; STORER R Treatment‐1st CoursRC

3171 RX Date Mst Defn Srg Flag NAACCR; STORER R Treatment‐1st CoursRC

3180 RX Date Surg Disch NAACCR; STORE. R Treatment‐1st Cours.

3181 RX Date Surg Disch Flag NAACCR; STORE. R Treatment‐1st Cours.

3190 Readm Same Hosp 30 Days NAACCR; STORE. R Treatment‐1st Cours.

3200 Rad‐‐Boost RX Modality NAACCR; STORE. . Treatment‐1st Cours.

3210 Rad‐‐Boost Dose cGy NAACCR; STORE. . Treatment‐1st Cours.

3220 RX Date Rad Ended NAACCR; STORE. R Treatment‐1st Cours.


3221 RX Date Rad Ended Flag NAACCR; STORE. R Treatment‐1st Cours.

3230 RX Date Systemic NAACCR; STORE. R Treatment‐1st CoursRC

3231 RX Date Systemic Flag NAACCR; STORE. R Treatment‐1st CoursRC

3250 RX Summ‐‐Transplnt/Endocr NAACCR; STORER R Treatment‐1st CoursR

3270 RX Summ‐‐Palliative Proc NAACCR; STORE. R Treatment‐1st Cours.

3280 RX Hosp‐‐Palliative Proc NAACCR; STORE. R Hospital‐Specific.

3300 RuralUrban Continuum 1993 NAACCRD . Demographic.

3310 RuralUrban Continuum 2003 NAACCRD . Demographic.

3312 RuralUrban Continuum 2013 NAACCRD . DemographicD

3400 Derived AJCC‐7 T NAACCR; STORERH* DH Stage/Prognostic FactDH

3402 Derived AJCC‐7 T Descript NAACCR; STORERH* DH Stage/Prognostic FactDH

3410 Derived AJCC‐7 N NAACCR; STORERH* DH Stage/Prognostic FactDH

3412 Derived AJCC‐7 N Descript NAACCR; STORERH* DH Stage/Prognostic FactDH

3420 Derived AJCC‐7 M NAACCR;STORERH* DH Stage/Prognostic FactDH

3422 Derived AJCC‐7 M Descript NAACCR; STORERH* DH Stage/Prognostic FactDH

3430 Derived AJCC‐7 Stage Grp NAACCR; STORERH* DH Stage/Prognostic FactDH

3440 Derived PreRx‐7 T NAACCR; AJCC. . Stage/Prognostic Fact.

3442 Derived PreRx‐7 T Descrip NAACCR; AJCC. . Stage/Prognostic Fact.

3450 Derived PreRx‐7 N NAACCR; AJCC. . Stage/Prognostic Fact.

3452 Derived PreRx‐7 N Descrip NAACCR; AJCC. . Stage/Prognostic Fact.

3460 Derived PreRx‐7 M NAACCR; AJCC. . Stage/Prognostic Fact.

3462 Derived PreRx‐7 M Descrip NAACCR; AJCC. . Stage/Prognostic Fact.


3470 Derived PreRx‐7 Stage Grp NAACCR; AJCC. . Stage/Prognostic Fact.

3480 Derived PostRx‐7 T NAACCR; AJCC. . Stage/Prognostic Fact.

3482 Derived PostRx‐7 N NAACCR; AJCC. . Stage/Prognostic Fact.

3490 Derived PostRx‐7 M NAACCR; AJCC. . Stage/Prognostic Fact.

3492 Derived PostRx‐7 Stge Grp NAACCR; AJCC. . Stage/Prognostic Fact.

3600 Derived Neoadjuv Rx Flag NAACCR; AJCC. . Stage/Prognostic Fact.

3605 Derived SEER Path Stg Grp SEER; NAACCR. . Stage/Prognostic FactDH

3610 Derived SEER Clin Stg Grp SEER; NAACCR. . Stage/Prognostic FactDH

3614 Derived SEER Cmb Stg Grp SEER; NAACCR. . Stage/Prognostic FactDH

3616 Derived SEER Combined T SEER; NAACCR. . Stage/Prognostic FactDH

3618 Derived SEER Combined N SEER; NAACCR. . Stage/Prognostic FactDH

3620 Derived SEER Combined M SEER; NAACCR. . Stage/Prognostic FactDH

3622 Derived SEER Cmb T Src SEER; NAACCR. . Stage/Prognostic FactDH

3624 Derived SEER Cmb N Src SEER; NAACCR. . Stage/Prognostic FactDH

3626 Derived SEER Cmb M Src SEER; NAACCR. . Stage/Prognostic FactDH

3645 NPCR Derived AJCC 8 TNM Clin Stg Gr NPCR. . Stage/Prognostic Fact.

3646 NPCR Derived AJCC 8 TNM Path Stg Gr NPCR. . Stage/Prognostic Fact.

3647 NPCR Derived AJCC 8 TNM Post Thera NPCR. . Stage/Prognostic Fact.

3650 NPCR Derived Clin Stg Grp NPCR; NAACCRRH . Stage/Prognostic Fact.

3655 NPCR Derived Path Stg Grp NPCR; NAACCRRH . Stage/Prognostic Fact.

3700 SEER Site‐Specific Fact 1 NAACCR; SEER. . Stage/Prognostic FactR

3702 SEER Site‐Specific Fact 2 NAACCR; SEER. . Stage/Prognostic Fact.






3720 NPCR Specific Field NPCR; NAACCRR . Stage/Prognostic Fact.

3750 Over‐ride CS 1 NAACCR; CoC. RH Edit Overrides/Conve.




















3769 Over‐ride CS 20 NAACCR; CoCRH RH Edit Overrides/ConveRH

3780 Secondary Diagnosis 1 NAACCR; STORE. R Stage/Prognostic Fact.










3800 Schema ID NAACCRD D Stage/Prognostic FactD

3801 Chromosome 1p: Loss of Heterozygosi NAACCR. RS Stage/Prognostic FactRS

3802 Chromosome 19q: Loss of Heterozygo NAACCR. RS Stage/Prognostic FactRS

3803 Adenoid Cystic Basaloid Pattern NAACCR. RS Stage/Prognostic FactRS

3804 Adenopathy NAACCR. RS Stage/Prognostic FactRS

3805 AFP Post‐Orchiectomy Lab Value NAACCR. RS Stage/Prognostic FactRC

3806 AFP Post‐Orchiectomy Range NAACCR. RS Stage/Prognostic FactRC

3807 AFP Pre‐Orchiectomy Lab Value NAACCR. RS Stage/Prognostic FactRC

3808 AFP Pre‐Orchiectomy Range NAACCR. RS Stage/Prognostic FactRC


3809 AFP Pretreatment Interpretation NAACCR. RS Stage/Prognostic FactRC

3810 AFP Pretreatment Lab Value NAACCR. RS Stage/Prognostic FactRC

3811 Anemia NAACCR. RS Stage/Prognostic FactRS

3812 B symptoms NAACCR. RS Stage/Prognostic FactRS

3813 Bilirubin Pretreatment Total Lab Value NAACCR. RS Stage/Prognostic FactRC

3814 Bilirubin Pretreatment Unit of Measur NAACCR. RS Stage/Prognostic FactRC

3815 Bone Invasion NAACCR. RS Stage/Prognostic FactRS

3816 Brain Molecular Markers NAACCRR . Stage/Prognostic FactRS

3817 Breslow Tumor Thickness NAACCRR RS Stage/Prognostic FactRS

3818 CA‐125 Pretreatment Interpretation NAACCR. RS Stage/Prognostic FactRS

3819 CEA Pretreatment Interpretation NAACCR. RS Stage/Prognostic FactRS

3820 CEA Pretreatment Lab Value NAACCR. RS Stage/Prognostic FactRS

3821 Chromosome 3 Status NAACCR. RS Stage/Prognostic FactRC

3822 Chromosome 8q Status NAACCR. RS Stage/Prognostic FactRC

3823 Circumferential Resection Margin (CR NAACCR. RS Stage/Prognostic FactRS

3824 Creatinine Pretreatment Lab Value NAACCR. RS Stage/Prognostic FactRC

3825 Creatinine Pretreatment Unit of Meas NAACCR. RS Stage/Prognostic FactRC

3826 Estrogen Receptor Percent Positive or NAACCR. RS Stage/Prognostic FactRC

3827 Estrogen Receptor Summary NAACCRR RS Stage/Prognostic FactRS

3828 Estrogen Receptor Total Allred Score NAACCRRN RS Stage/Prognostic FactRC

3829 Esophagus and EGJ Tumor Epicenter NAACCR. RS Stage/Prognostic FactRS

3830 Extranodal Extension Clin (non‐Head a NAACCR. RS Stage/Prognostic FactRC


3831 Extranodal Extension Head and Neck C NAACCR. RS Stage/Prognostic FactRC

3832 Extranodal Extension Head and Neck P NAACCR. RS Stage/Prognostic FactRS

3833 Extranodal Extension Path (non‐Head NAACCR. RS Stage/Prognostic FactRC

3834 Extravascular Matrix Patterns NAACCR. RS Stage/Prognostic FactRC

3835 Fibrosis Score NAACCRR RS Stage/Prognostic FactRC

3836 FIGO Stage NAACCR. RS Stage/Prognostic FactRS

3837 Gestational Trophoblastic Prognostic S NAACCR. RS Stage/Prognostic FactRS

3838 Gleason Patterns Clinical NAACCR. RS Stage/Prognostic FactRS

3839 Gleason Patterns Pathological NAACCR. RS Stage/Prognostic FactRS

3840 Gleason Score Clinical NAACCR. RS Stage/Prognostic FactRC

3841 Gleason Score Pathological NAACCR. RS Stage/Prognostic FactRC

3842 Gleason Tertiary Pattern NAACCR. RS Stage/Prognostic FactRC

3843 Grade Clinical NAACCRR R Stage/Prognostic FactR

3844 Grade Pathological NAACCRRN R Stage/Prognostic FactR

3845 Grade Post Therapy NAACCRRN R Stage/Prognostic FactRS

3846 hCG Post‐Orchiectomy Lab Value NAACCR. RS Stage/Prognostic FactRC

3847 hCG Post‐Orchiectomy Range NAACCR. RS Stage/Prognostic FactRS

3848 hCG Pre‐Orchiectomy Lab Value NAACCR. RS Stage/Prognostic FactRC

3849 hCG Pre‐Orchiectomy Range NAACCR. RS Stage/Prognostic FactRS

3850 HER2 IHC Summary NAACCR. RS Stage/Prognostic FactRS*

3851 HER2 ISH Dual Probe Copy Number NAACCR. RS Stage/Prognostic FactRS*

3852 HER2 ISH Dual Probe Ratio NAACCR. RS Stage/Prognostic FactRS*


3853 HER2 ISH Single Probe Copy Number NAACCR. RS Stage/Prognostic FactRS*

3854 HER2 ISH Summary NAACCR. RS Stage/Prognostic FactRS*

3855 HER2 Overall Summary NAACCRR RS Stage/Prognostic FactRS

3856 Heritable Trait NAACCR. RS Stage/Prognostic FactRS

3857 High Risk Cytogenetics NAACCR. RS Stage/Prognostic FactRS

3858 High Risk Histologic Features NAACCR. RS Stage/Prognostic FactRS

3859 HIV Status NAACCR. RS Stage/Prognostic FactRS

3860 International Normalized Ratio Prothr NAACCR. RS Stage/Prognostic FactRC

3861 Ipsilateral Adrenal Gland Involvement NAACCR. RS Stage/Prognostic FactRS

3862 JAK2 NAACCR. RS Stage/Prognostic FactRS

3863 Ki‐67 NAACCR. RS Stage/Prognostic FactRC

3864 Invasion Beyond Capsule NAACCR. RS Stage/Prognostic FactRS

3865 KIT Gene Immunohistochemistry NAACCR. RS Stage/Prognostic FactRC

3866 KRAS NAACCR. RS Stage/Prognostic FactRS

3867 LDH Post‐Orchiectomy Range NAACCR. RS Stage/Prognostic FactRS

3868 LDH Pre‐Orchiectomy Range NAACCR. RS Stage/Prognostic FactRS

3869 LDH Pretreatment Level NAACCR. RS Stage/Prognostic FactRS

3870 LDH Upper Limits of Normal NAACCR. RS Stage/Prognostic FactRC

3871 LN Assessment Method Femoral‐Ingui NAACCR. RS Stage/Prognostic FactRC

3872 LN Assessment Method Para‐Aortic NAACCR. RS Stage/Prognostic FactRC

3873 LN Assessment Method Pelvic NAACCR. RS Stage/Prognostic FactRC

3874 LN Distant Assessment Method NAACCR. RS Stage/Prognostic FactRC


3875 LN Distant: Mediastinal Scalene NAACCR. RS Stage/Prognostic FactRC

3876 LN Head and Neck Levels I‐III NAACCR. RS Stage/Prognostic FactRS

3877 LN Head and Neck Levels IV‐V NAACCR. RS Stage/Prognostic FactRS

3878 LN Head and Neck Levels VI‐VII NAACCR. RS Stage/Prognostic FactRS

3879 LN Head and Neck Other NAACCR. RS Stage/Prognostic FactRS

3880 LN Isolated Tumor Cells (ITC) NAACCR. RS Stage/Prognostic FactRS

3881 LN Laterality NAACCR. RS Stage/Prognostic FactRS

3882 LN Positive Axillary Level I‐II NAACCR. RS Stage/Prognostic FactRS

3883 LN Size NAACCR. RS Stage/Prognostic FactRS

3884 LN Status Femoral‐Inguinal Para‐Aorti NAACCR. RS Stage/Prognostic FactRS

3885 Lymphocytosis NAACCR. RS Stage/Prognostic FactRS

3886 Major Vein Involvement NAACCR. RS Stage/Prognostic FactRS

3887 Measured Basal Diameter NAACCR. RS Stage/Prognostic FactRS

3888 Measured Thickness NAACCR. RS Stage/Prognostic FactRS

3889 Methylation of O6‐Methylguanine‐Me NAACCR. RS Stage/Prognostic FactRS

3890 Microsatellite Instability (MSI) NAACCRRS* RS Stage/Prognostic FactRS

3891 Microvascular Density NAACCR. RS Stage/Prognostic FactRC

3892 Mitotic Count Uveal Melanoma NAACCR. RS Stage/Prognostic FactRC

3893 Mitotic Rate Melanoma NAACCR. RS Stage/Prognostic FactRS

3894 Multigene Signature Method NAACCR. RS Stage/Prognostic FactRS

3895 Multigene Signature Results NAACCR. RS Stage/Prognostic FactRS

3896 NCCN International Prognostic Index (I NAACCR. RS Stage/Prognostic FactRS


3897 Number of Cores Examined NAACCR. RS Stage/Prognostic FactRS

3898 Number of Cores Positive NAACCR. RS Stage/Prognostic FactRS

3899 Number of Examined Para‐Aortic Nod NAACCR. RS Stage/Prognostic FactRC

3900 Number of Examined Pelvic Nodes NAACCR. RS Stage/Prognostic FactRC

3901 Number of Positive Para‐Aortic Nodes NAACCR. RS Stage/Prognostic FactRC

3902 Number of Positive Pelvic Nodes NAACCR. RS Stage/Prognostic FactRC

3903 Oncotype Dx Recurrence Score‐DCIS NAACCR. RS Stage/Prognostic FactRC

3904 Oncotype Dx Recurrence Score‐Invasiv NAACCR. RS Stage/Prognostic FactRS

3905 Oncotype Dx Risk Level‐DCIS NAACCR. RS Stage/Prognostic FactRC

3906 Oncotype Dx Risk Level‐Invasive NAACCR. RS Stage/Prognostic FactRC

3907 Organomegaly NAACCR. RS Stage/Prognostic FactRS

3908 Percent Necrosis Post Neoadjuvant NAACCR. RS Stage/Prognostic FactRC

3909 Perineural Invasion NAACCR. RS Stage/Prognostic FactRS

3910 Peripheral Blood Involvement NAACCR. RS Stage/Prognostic FactRS

3911 Peritoneal Cytology NAACCR. RS Stage/Prognostic FactRS

3913 Pleural Effusion NAACCR. RS Stage/Prognostic FactRS

3914 Progesterone Receptor Percent Positiv NAACCR. RS Stage/Prognostic FactRC

3915 Progesterone Receptor Summary NAACCRR RS Stage/Prognostic FactRS

3916 Progesterone Receptor Total Allred Sc NAACCRRN RS Stage/Prognostic FactRC

3917 Primary Sclerosing Cholangitis NAACCR. RS Stage/Prognostic FactRC

3918 Profound Immune Suppression NAACCR. RS Stage/Prognostic FactRS

3919 Prostate Pathological Extension NAACCR. RS Stage/Prognostic FactRS


3920 PSA (Prostatic Specific Antigen) Lab Va NAACCRR RS Stage/Prognostic FactRS

3921 Residual Tumor Volume Post Cytoredu NAACCR. RS Stage/Prognostic FactRS

3922 Response to Neoadjuvant Therapy NAACCR. RS Stage/Prognostic FactRC

3923 S Category Clinical NAACCR. RS Stage/Prognostic FactRS

3924 S Category Pathological NAACCR. RS Stage/Prognostic FactRS

3925 Sarcomatoid Features NAACCR. RS Stage/Prognostic FactRS

3926 Schema Discriminator 1 NAACCRR RS Stage/Prognostic FactRS

3927 Schema Discriminator 2 NAACCRR RS Stage/Prognostic FactRS

3928 Schema Discriminator 3 NAACCR. RS Stage/Prognostic FactRS

3929 Separate Tumor Nodules NAACCR. RS Stage/Prognostic FactRS

3930 Serum Albumin Pretreatment Level NAACCR. RS Stage/Prognostic FactRS

3931 Serum Beta‐2 Microglobulin Pretreat NAACCR. RS Stage/Prognostic FactRS

3932 LDH Pretreatment Lab Value NAACCRR RS Stage/Prognostic FactRS

3933 Thrombocytopenia NAACCR. RS Stage/Prognostic FactRS

3934 Tumor Deposits NAACCR. RS Stage/Prognostic FactRS

3935 Tumor Growth Pattern NAACCR. RS Stage/Prognostic FactRS

3936 Ulceration NAACCR. RS Stage/Prognostic FactRS

3937 Visceral and Parietal Pleural Invasion NAACCR. RS Stage/Prognostic FactRS

7010 Path Reporting Fac ID 1 NAACCR; HL7. . Pathology.






7090 Path Report Number 1 NAACCR; HL7. . Pathology.





7100 Path Order Phys Lic No 1 NAACCR; HL7. . Pathology.





7190 Path Ordering Fac No 1 NAACCR; HL7. . Pathology.





7320 Path Date Spec Collect 1 NAACCR; HL7. . Pathology.





7480 Path Report Type 1 NAACCR; HL7. . Pathology.






9960 Height CER ‐ Required for Breast, Colorectoal, CML and all oth Demographic

9961 Weight CER ‐ Required for Breast, Colorectoal, CML and all oth Demographic

9965 Tobacco Use: Cigarette CER ‐ All, as available Not Known

9966 Tobacco Use: Other Smoke CER ‐ All, as available Not Known

9967 Tobacco Use: Smokeless Tobacco CER ‐ All, as available Not Known

9968 Tobacco Use: NOS CER ‐ All, as available Not Known

9970 Sources Comorbid/Complications CER ‐ All Not Known

9980 NBCCEDP MDE Linkage Results Breast, Cervix Not Known

9981 NBCCEDP MDE Linkage Date Breast, Cervix Not Known

9982 RMCD Master File Number CDRI Not Known

9983 DoNotContact CDRI Not Known

9984 GIS Quality Code CDRI Not Known

9985 Path Lab ID CDRI Not Known

9986 NPAIHBLink CDRI Not Known

9987 DCO Category CDRI Not Known

11001 Date PCOR Complete CDRI Not Known

11002 PCORComplete CDRI Not Known

11011 Clinical Trial Enrollment CDRI Not Known


11013 Clinical Trial Date CDRI Not Known

11017 Clinical Trial Text CDRI Not Known

Idaho - Minimum Dataset and Data Dictionary - 2018 · Idaho - Minimum Dataset and Data Dictionary -...

Documents

Transcript of Idaho - Minimum Dataset and Data Dictionary - 2018 · Idaho - Minimum Dataset and Data Dictionary -...